UNSPSC 51283961: Glucosulfamide

This classification denotes a sulfonamide anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X40L29981F. European Medicines Agency schedules Glucosulfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07938MIG. Glucosulfamide generally arises in the molecular formula C13H21N2O11S2.NA. The term GLUCOSULFAMIDE is an International Non-Proprietary Name or INN.

GLUCOSULFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(O)C(NC1CCC(S(=O)(=O)NCO)CC1)C(O)C(O)C(O)C(O)CO.[NA].

UNSPSC 51283961 Glucosulfamide is a Commodity code that shows limited alignment between its nominal scope and recent state and local solicitation activity. The recent opportunities tagged to this code do not involve glucosulfamide — a sulfanilamide compound used in pharmaceutical manufacturing — but instead cover emergency medical supplies, naloxone distribution, and multi-source pharmaceutical procurement across state health agencies and local government. State and local buyers are not currently soliciting glucosulfamide through active RFPs, RFQs, ITBs, or IFBs in the available recent-opportunities record.

The misalignment between the code's nominal scope and actual procurement activity signals that this Commodity code either sees minimal state and local purchasing volume or has been incorrectly applied to opportunities in adjacent pharmaceutical supply categories. Business development professionals should verify that their target markets and customers actually use this code before pursuing opportunities tagged to it, and should expect to find more relevant activity under broader pharmaceutical or medical-supply Family or Class codes if their product or service aligns with the emergency medical, generic pharmaceutical, or OTC supply categories currently appearing in state and local solicitations.